SterileAtlas Marketplaces

DiscoveryAcademic Preclinical Labs Process Dev (PDO)CDMOs

ClinicalCROs Clinical Sites Ethics / IRB Central Labs

QualityPharmacovigilance Regulatory Engineering Consultants

SupplySuppliers Equipment Packaging

DistributionLogistics Distribution Specialty Pharmacy

AccessPayers PBM

CapitalInvestors IP & Legal

SterileAtlasIntelligence Mission Control

Loading…

SterileAtlas

One marketplace for the entire drug lifecycle — global sterile pharmaceutical & biotech manufacturing intelligence.

Marketplaces

All 22 marketplaces
CDMOs
CROs
Clinical trial sites
Consultants

Opportunities

Projects, jobs & leads
Open projects
Jobs
Consulting leads

Platform

Pricing
About us
List your company
Mission Control

© 2026 SterileAtlas · Capability scores are deterministic, rules-based — not AI.

About us Terms Usage Policy Disclosures Compliance Community guidelines Privacy Cookies Refunds DPA Trust & security

Data shown across the platform is illustrative and unverified — not for vendor qualification or regulatory use.

Discovery & Development

CDMOs

Contract development & manufacturing

27

CDMOs listed

Drug substance, drug product, advanced-therapy and sterile fill-finish manufacturers — ranked on transparent capability scores.

SearchFaceted, over real records CompareSide-by-side scorecards Post an RFxGet qualified responses CollaborateRun it in a shared room AI assistantYour organisation, this market

Scores are deterministic, rules-based — not AI.

MarketplacesCDMOs

27 providers

Sort

Manufacturing breadth Advanced therapy Fill-finish capacity Quality & compliance Regulatory reach Capacity & scale Name (A–Z)

Technology platforms

000 L2 antibody-drug conjugates2 000 L at Cranbury1 000 L at Worcester); Vanrx robotic aseptic filling isolator for liquid filling into 2R/6R/10R (up to 20R) vials and 1 mL / 2.25 mL prefilled syringes1 000 L) and stainless steel formulation (1-41 000 L); seven fully isolated filling lines for vials1 Activ-Blister solutions1 Adaptdose1 adenovirus); continuous flow processing; simulated moving bed (SMB) chromatography; biocatalysis; catalyst design; particle engineering; energetic chemistry1 AdvaTab1 analytical ultracentrifugation (AUC)1 and aseptic insertion technology for components such as tip/cap assemblies; secondary and bulk packaging1 antibody discovery and engineering1 Antibody drug conjugates (ADC); hot melt extrusion; fully automated isolator aseptic filling line with potent containment; 23 square-metre auto-load lyophiliser1 Aseptic fill/finish of liquid and lyophilized vials and prefilled syringes; lyophilization cycle development; closed RABS with isolators and specialized containment for cytotoxic and highly potent products; bioconjugation listed as "coming soon"1 assembly1

Availability

Accepting new projects100 Verified0

Annual capacity

Any annual capacity ≥ 10k batches / yr ≥ 50k batches / yr ≥ 250k batches / yr ≥ 1M batches / yr

Cleanroom suites

Any suite count ≥ 3 suites ≥ 8 suites ≥ 20 suites ≥ 40 suites

Facilities

Any facility count ≥ 5 facilities ≥ 10 facilities ≥ 20 facilities

Company headcount

Any headcount ≥ 2,500 employees ≥ 5,000 employees ≥ 10,000 employees

Modalities

Small molecules46 Biologics (drug substance)44 mRNA16 HPAPI40 Peptides24 Oligonucleotides16 Plasmid DNA6

Advanced therapy

Cell therapy21 Gene therapy18 Viral vectors19 CAR-T4

Dosage forms

Sterile injectables67 Ophthalmics4 Vaccines19 Oral solids42 Liquids41 Semi-solids6 Lyophilization50

Fill-finish

Vial filling58 Prefilled syringe49 Cartridge filling20 Isolator30 RABS14 Blow-fill-seal11

Services

Process development93 Clinical manufacturing80 Commercial manufacturing89 Packaging51 Tech transfer54

Special handling

Controlled substances7 Combination products7

Quality & regulatory

GMP certified0 Annex 10 Data-integrity program0

Quality score

Any quality score ≥ 85 quality score ≥ 90 quality score ≥ 92 quality score

On-time delivery

Any on-time rate ≥ 94% on-time delivery ≥ 95% on-time delivery ≥ 96% on-time delivery

Inspection pass rate

Any pass rate ≥ 95% inspection pass ≥ 97% inspection pass ≥ 98% inspection pass

Ownership

Private33 Subsidiary27 PE-backed25 Public15

Provider type

Biologics CDMO28 CDMO23 Integrated CDMO22 Sterile Fill-Finish21 API Manufacturer6

Region

Europe40 North America30 Asia17 Japan5 China4 United States2 Oceania1 South America1

Location

United States27

Bloomington2 Philadelphia2 Cranbury1 Durham1 Fishers1 Grand Rapids1 Nashville1 Norman1 North Chicago1 Norwalk1 Raleigh1 Rancho Cordova1 San Diego1 Spokane1 Tampa1 Tustin1 Whippany1 Wilmington1 Woodbury1 Woodstock1

United Kingdom4

Showing 1 of 27Clear filters United States Raleigh

Biologics CDMO · Raleigh, United States

12breadth

BiologicsHPAPI

ADV 14FF 00 suites

AvailableFocused